Works matching IS 00071188 AND DT 2021 AND VI 178 AND IP 13

Results: 12

Correction.

Published in:: 2021
Publication type:: corrected article

Cardiovascular and temperature adverse actions of stimulants.

Published in:

2021

By:

Docherty, James R.;
Alsufyani, Hadeel A.

Publication type:

journal article

Differential mode of cholesterol inclusion with 2-hydroxypropyl-cyclodextrins increases safety margin in treatment of Niemann-Pick disease type C.

Published in:

2021

By:

Yamada, Yusei;
Ishitsuka, Yoichi;
Kondo, Yuki;
Nakahara, Shuichi;
Nishiyama, Asami;
Takeo, Toru;
Nakagata, Naomi;
Motoyama, Keiichi;
Higashi, Taishi;
Arima, Hidetoshi;
Kamei, Shunsuke;
Shuto, Tsuyoshi;
Kai, Hirofumi;
Hayashino, Yuji;
Sugita, Masatake;
Kikuchi, Takeshi;
Hirata, Fumio;
Miwa, Toru;
Takeda, Hiroki;
Orita, Yorihisa

Publication type:

journal article

Identification and characterization of novel candidate compounds targeting 6- and 7-transmembrane μ-opioid receptor isoforms.

Published in:

2021

By:

Muralidharan, Arjun;
Samoshkin, Alexander;
Convertino, Marino;
Piltonen, Marjo Hannele;
Gris, Pavel;
Wang, Jian;
Jiang, Changyu;
Klares, Richard;
Linton, Alexander;
Ji, Ru‐Rong;
Maixner, William;
Dokholyan, Nikolay V.;
Mogil, Jeffrey S.;
Diatchenko, Luda;
Klares, Richard 3rd;
Ji, Ru-Rong

Publication type:

journal article

Elevation of propofol sensitivity of cardiac IKs channel by KCNE1 polymorphism D85N.

Published in:

2021

By:

Kojima, Akiko;
Mi, Xinya;
Fukushima, Yutaka;
Ding, Wei‐Guang;
Omatsu‐Kanbe, Mariko;
Matsuura, Hiroshi;
Ding, Wei-Guang;
Omatsu-Kanbe, Mariko

Publication type:

journal article

Functional brain imaging in larval zebrafish for characterising the effects of seizurogenic compounds acting via a range of pharmacological mechanisms.

Published in:

2021

By:

Winter, Matthew J.;
Pinion, Joseph;
Tochwin, Anna;
Takesono, Aya;
Ball, Jonathan S.;
Grabowski, Piotr;
Metz, Jeremy;
Trznadel, Maciej;
Tse, Karen;
Redfern, Will S.;
Hetheridge, Malcolm J.;
Goodfellow, Marc;
Randall, Andrew D.;
Tyler, Charles R.

Publication type:

journal article

Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy.

Published in:

2021

By:

Liu, Chenglong;
Zhou, Feilong;
Yan, Ziqin;
Shen, Lian;
Zhang, Xichen;
He, Fenglian;
Wang, Heng;
Lu, Xiaojie;
Yu, Ker;
Zhao, Yujun;
Zhu, Di

Publication type:

journal article

N-acetylcysteine as a new prominent approach for treating psychiatric disorders.

Published in:

2021

By:

Smaga, Irena;
Frankowska, Małgorzata;
Filip, Małgorzata

Publication type:

journal article

Identification of WP1066, an inhibitor of JAK2 and STAT3, as a KV 1.3 potassium channel blocker.

Published in:

2021

By:

Li, Min;
Yu, Haibo

Publication type:

journal article

Doxycycline and its derivative, COL-3, decrease dyskinesia induced by l-DOPA in hemiparkinsonian rats.

Published in:

2021

By:

Bortolanza, Mariza;
Nascimento, Glauce C.;
Raisman‐Vozari, Rita;
Del‐Bel, Elaine;
Nascimento, Glauce C do;
Raisman-Vozari, Rita;
Del-Bel, Elaine;
do Nascimento, Glauce C

Publication type:

journal article

Issue Information.

Published in:: British Journal of Pharmacology, 2021, v. 178, n. 13, p. 2549, doi. 10.1111/bph.15118
Publication type:: Article

Fluorescent- and tagged-protoxin II peptides: potent markers of the Nav 1.7 channel pain target.

Published in:

2021

By:

Montnach, Jérôme;
De Waard, Stephan;
Nicolas, Sébastien;
Burel, Sophie;
Osorio, Nancy;
Zoukimian, Claude;
Mantegazza, Massimo;
Boukaiba, Rachid;
Béroud, Rémy;
Partiseti, Michel;
Delmas, Patrick;
Marionneau, Céline;
De Waard, Michel

Publication type:

journal article

Works matching IS 00071188 AND DT 2021 AND VI 178 AND IP 13

Correction.

Cardiovascular and temperature adverse actions of stimulants.

Differential mode of cholesterol inclusion with 2-hydroxypropyl-cyclodextrins increases safety margin in treatment of Niemann-Pick disease type C.

Identification and characterization of novel candidate compounds targeting 6- and 7-transmembrane μ-opioid receptor isoforms.

Elevation of propofol sensitivity of cardiac I<sub>Ks</sub> channel by KCNE1 polymorphism D85N.

Functional brain imaging in larval zebrafish for characterising the effects of seizurogenic compounds acting via a range of pharmacological mechanisms.

Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy.

N-acetylcysteine as a new prominent approach for treating psychiatric disorders.

Identification of WP1066, an inhibitor of JAK2 and STAT3, as a K<sub>V</sub> 1.3 potassium channel blocker.

Doxycycline and its derivative, COL-3, decrease dyskinesia induced by l-DOPA in hemiparkinsonian rats.

Issue Information.

Fluorescent- and tagged-protoxin II peptides: potent markers of the Na<sub>v</sub> 1.7 channel pain target.